News

Gd-LKZdW8AEDs0K
Philadelphia, December 2, 2024 – XCMR today announced its participation in the 2024 Chemical and Biological Defense Science & Technology (CBD S&T) Conference.
Nancy Havill
Expert in epidemiology and infection prevention Nancy Havill, MS, CIC, joins XCMR as Senior Director of Infection Prevention.
opengraph
XCMR today announced that it is presenting at BioFuture 2024, a future focused conference that convenes trailblazers, disruptors, and forward-thinkers who are shaping the future of science and healthcare.
chris-jones
We’re thrilled to announce that Christopher Jones, who joined XCMR as principal engineer, has been promoted to chief technology officer (CTO). Chris has been an integral part of the XCMR team since February 2023, and his passion for innovation and problem-solving has already made a significant impact.
rob-board-director
XCMR is pleased to announce the appointment of Robert Douglas to its board of directors. Mr. Douglas brings a wealth of experience in the medical device industry, with particular expertise in digital health technologies and corporate governance.
flu-news-img
“Better preventing the spread of influenza – whether from a seasonal or pandemic strain – requires thoughtful investment in innovative new approaches, including non-pharmaceutical interventions,” said Coalition to Stop Flu Chairman and former Senate Majority Leader Tom Daschle. “We are delighted to welcome XCMR’s perspective to the Coalition.”

Let's Partner.